speb/financial-data huggingface dataset:
Financial ratios for SAM — quarterly report dated 2025-03-31
Total revenue: 481357000
Gross profit: 219263000
Operating income: 33776000
Net income: 24412000
Capital expenditures: 9879000
Operating cash flow: 1939000
Depreciation & amortization: 22814000
Net tangible assets: 768458000
Owner earnings: 37347000
Return on net tangible assets (%): 4.859992348313115
Capex to operating income (%): 29.24857887257224
Buffett classification: The Good
Stock price: 238.84
P/E ratio: 20.41235219646076
Shares outstanding: 8345442
Book value: 897010000
P/B ratio: 2.222077086409293
Market cap (USD): 1993225367.28
Debt to equity: 0.052229072139664
Current ratio: 1.7178820632097414
Quick ratio: 1.1156523505682077
Effective tax rate (%): 31.89186173032391
COGS to revenue (%): 48.7380468134877
SG&A to revenue (%): 38.53418564599663
Free cash flow (dilution-adjusted): -13852000
Buyback yield (%): 2.478094088648097
Retained earnings: 215111000
Inventory turnover: 1.615107121220466
Receivables turnover: 5.482176210650995
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.3808896055862356
FCF margin (%): -2.877697841726619
Rule of 40 score: -2.877697841726619
Financial ratios for SAM — quarterly report dated 2025-06-30
Total revenue: 625425000
Gross profit: 292518000
Operating income: 87054000
Net income: 60433000
Capital expenditures: 14235000
Operating cash flow: 126480000
Depreciation & amortization: 22364000
Net tangible assets: 784210000
Owner earnings: 68562000
Return on net tangible assets (%): 8.742811236786064
Capex to operating income (%): 16.35191949824247
Buffett classification: The Great
Stock price: 190.81
P/E ratio: 18.768269055571924
Shares outstanding: 8345442
Book value: 912339000
P/B ratio: 1.7453970377458379
Market cap (USD): 1592393788.02
Debt to equity: 0.04807642773135863
Current ratio: 1.7611482762265747
Quick ratio: 1.2538884945863096
Effective tax rate (%): 28.102172412972614
COGS to revenue (%): 47.23683894951433
SG&A to revenue (%): 32.85190070751889
Free cash flow (dilution-adjusted): 107191000
Buyback yield (%): 3.27952799068217
Retained earnings: 225115000
Inventory turnover: 2.198719904737097
Receivables turnover: 6.734486211760652
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.676585061012378
FCF margin (%): 17.138905544229925
Revenue growth (%): 29.92955332528664
Rule of 40 score: 47.06845886951656
Financial ratios for SAM — quarterly report dated 2025-09-30
Total revenue: 571476000
Gross profit: 273117000
Operating income: 63465000
Net income: 46155000
Capital expenditures: 12556000
Operating cash flow: 101799000
Depreciation & amortization: 22548000
Net tangible assets: 783279000
Owner earnings: 56147000
Return on net tangible assets (%): 7.168199326166028
Capex to operating income (%): 19.784132986685574
Buffett classification: The Great
Stock price: 211.42
P/E ratio: 13.46865150870229
Shares outstanding: 8345442
Book value: 910984000
P/B ratio: 1.9367994911436424
Market cap (USD): 1764393347.6399999
Debt to equity: 0.04489321437039509
Current ratio: 1.8284426881852414
Quick ratio: 1.4256979612523113
Effective tax rate (%): 28.051441932969603
COGS to revenue (%): 46.262135242774846
SG&A to revenue (%): 36.68605505743023
Free cash flow (dilution-adjusted): 85754000
Buyback yield (%): 2.879516637713274
Retained earnings: 220773000
Inventory turnover: 2.5991682724448464
Receivables turnover: 6.639048305025675
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.384526238275166
FCF margin (%): 15.0057045265243
Revenue growth (%): -8.625974337450534
Rule of 40 score: 6.379730189073765
Financial ratios for SAM — quarterly report dated 2025-12-31
Total revenue: 408993000
Gross profit: 167682000
Operating income: -32459000
Net income: -22531000
Capital expenditures: 17846000
Operating cash flow: 39940000
Depreciation & amortization: 22712000
Net tangible assets: 718998000
Owner earnings: -17665000
Return on net tangible assets (%): -2.4568913960817693
Buffett classification: The Gruesome
Stock price: 195.13
P/E ratio: 15.013009223464769
Shares outstanding: 8345442
Book value: 846280000
P/B ratio: 1.9242403193505697
Market cap (USD): 1628446097.46
Debt to equity: 0.04475232783475918
Current ratio: 1.6535555608353727
Quick ratio: 1.2871415334172824
COGS to revenue (%): 53.30213475536256
SG&A to revenue (%): 48.93506734834093
Free cash flow (dilution-adjusted): 14748000
Buyback yield (%): 3.070473138655926
Retained earnings: 147744000
Inventory turnover: 2.355963342411274
Receivables turnover: 5.027386820399985
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.4491919227340206
FCF margin (%): 3.605929685838144
Revenue growth (%): -28.432165130294184
Rule of 40 score: -24.82623544445604
Financial ratios for SAM — annual report dated 2025-12-31
Total revenue: 2087251000
Gross profit: 952580000
Operating income: 151837000
Net income: 108469000
Capital expenditures: 54516000
Operating cash flow: 270158000
Depreciation & amortization: 90438000
Net tangible assets: 718998000
Owner earnings: 144391000
Return on net tangible assets (%): 20.082253358145643
Capex to operating income (%): 35.90429210271541
Buffett classification: The Good
Stock price: 195.13
P/E ratio: 15.013009223464769
Shares outstanding: 8345442
Book value: 846280000
P/B ratio: 1.9242403193505697
Market cap (USD): 1628446097.46
Debt to equity: 0.04475232783475918
Current ratio: 1.6535555608353727
Quick ratio: 1.2871415334172824
Effective tax rate (%): 29.317737521178156
COGS to revenue (%): 48.50465995704398
SG&A to revenue (%): 38.36352216384134
Free cash flow (dilution-adjusted): 193841000
Buyback yield (%): 12.430500482376095
Retained earnings: 147744000
Inventory turnover: 10.941231141659102
Receivables turnover: 25.656718252553684
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.134660771193367
FCF margin (%): 9.286904162460576
Revenue growth (%): -2.364624974623468
Rule of 40 score: 6.922279187837108
Financial ratios for SFZN.SW — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 95.94505494505495
Shares outstanding: 43808440
Market cap (USD): 4203203182.857143
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SFZN.SW — annual report dated 2022-12-31
Total revenue: 1336432608.695652
Gross profit: 346619565.2173913
Operating income: 248888043.47826084
Net income: 170097826.0869565
Capital expenditures: 112467391.30434783
Operating cash flow: 154717391.3043478
Depreciation & amortization: 88856521.73913044
Net tangible assets: 820733695.6521739
Owner earnings: 146486956.52173913
Return on net tangible assets (%): 17.848293215905706
Capex to operating income (%): 45.18794464072811
Buffett classification: The Good
Stock price: 65.79347826086956
P/E ratio: 16.945011650584703
Shares outstanding: 43808440
Book value: 859704347.8260868
P/B ratio: 3.3526754308862508
Market cap (USD): 2882309644.7826085
Debt to equity: 0
Current ratio: 2.9751412180330865
Quick ratio: 1.697465947089681
Effective tax rate (%): 28.46956219660472
Interest coverage ratio: 30.12855263157895
COGS to revenue (%): 74.06382013114083
R&D to revenue (%): 3.5115386679983542
SG&A to revenue (%): 4.001324096109207
Free cash flow (dilution-adjusted): 18250000
Buyback yield (%): 0.9088801120953335
Retained earnings: 677969565.2173913
Inventory turnover: 2.2441310851639553
Receivables turnover: 3.64013654383051
Capitalized R&D asset: 46929347.82608695
ROCI (R&D-adjusted, %): 16.971527385010305
FCF margin (%): 1.3655757784757931
Rule of 40 score: 1.3655757784757931
Financial ratios for SFZN.SW — annual report dated 2023-12-31
Total revenue: 1513683333.3333335
Gross profit: 381438095.2380952
Operating income: 200794047.6190476
Net income: 134254761.9047619
Capital expenditures: 151364285.71428573
Operating cash flow: 248342857.14285716
Depreciation & amortization: 96848809.52380952
Net tangible assets: 945675000
Owner earnings: 79739285.7142857
Return on net tangible assets (%): 8.431996797450044
Capex to operating income (%): 75.38285497459492
Buffett classification: The Gruesome
Stock price: 100.95238095238095
P/E ratio: 32.941597460407536
Shares outstanding: 43808440
Book value: 997778571.4285715
P/B ratio: 4.432412611825794
Market cap (USD): 4422566323.809524
Debt to equity: 0
Current ratio: 2.471503267973856
Quick ratio: 1.3856862745098042
Effective tax rate (%): 25.058519976592013
Interest coverage ratio: 18.136236559139782
COGS to revenue (%): 74.80066756115247
R&D to revenue (%): 3.500055839823074
SG&A to revenue (%): 8.558671924523434
Free cash flow (dilution-adjusted): 73821428.57142857
Buyback yield (%): 0.1745108287309779
Retained earnings: 793442857.1428572
Inventory turnover: 2.2019039769596565
Receivables turnover: 3.660481867358367
Capitalized R&D asset: 84422424.94824018
ROCI (R&D-adjusted, %): 12.067838875499246
Rosenberg metric: 0.7419350925083406
FCF margin (%): 4.876940040613639
Revenue growth (%): 13.26297513876714
Rule of 40 score: 18.13991517938078
Financial ratios for SFZN.SW — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 1027000000
Buffett classification: The Gruesome
Stock price: 108.53333333333333
Shares outstanding: 43808440
Book value: 1088786666.6666667
P/B ratio: 4.366949161758042
Market cap (USD): 4754676021.333333
Debt to equity: 0
Current ratio: 3.063855394179368
Quick ratio: 1.799728635775068
Buyback yield (%): 0
Retained earnings: 929907777.7777778
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SFZN.SW — annual report dated 2024-12-31
Total revenue: 1438414444.4444444
Gross profit: 365618888.8888889
Operating income: 216400000
Net income: 177848888.8888889
Capital expenditures: 183182222.2222222
Operating cash flow: 187530000
Depreciation & amortization: 94140000
Net tangible assets: 1027000000
Owner earnings: 88806666.66666669
Return on net tangible assets (%): 8.64719246997728
Capex to operating income (%): 84.64982542616552
Buffett classification: The Gruesome
Stock price: 108.53333333333333
P/E ratio: 26.73435887644942
Shares outstanding: 43808440
Book value: 1088786666.6666667
P/B ratio: 4.366949161758042
Market cap (USD): 4754676021.333333
Debt to equity: 0
Current ratio: 3.063855394179368
Quick ratio: 1.799728635775068
Effective tax rate (%): 18.535370004279862
Interest coverage ratio: 22.91294117647059
COGS to revenue (%): 74.58181191790652
R&D to revenue (%): 3.175950680262913
SG&A to revenue (%): 7.597949285208328
Free cash flow (dilution-adjusted): -13945555.555555554
Buyback yield (%): 0.4380716750296676
Retained earnings: 929907777.7777778
Inventory turnover: 2.4911398936993656
Receivables turnover: 3.2773336236228126
Capitalized R&D asset: 96666458.59213251
ROCI (R&D-adjusted, %): 11.212572731256914
Rosenberg metric: -0.29858960819120767
FCF margin (%): -0.9695088650852443
Revenue growth (%): -4.97256508223136
Rule of 40 score: -5.942073947316604
Financial ratios for SFZN.SW — quarterly report dated 2025-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 111.05
Shares outstanding: 43808440
Market cap (USD): 4864927262
Quick ratio: -1.455741338750409
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLBEN.LS — annual report dated 2021-06-30
Gross profit: 109878571.42857143
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.75
Shares outstanding: 23000000
Market cap (USD): 86250000
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLBEN.LS — annual report dated 2022-06-30
Total revenue: 176392708.33333334
Gross profit: 174151041.6666667
Operating income: -69146875
Net income: -36476041.66666667
Capital expenditures: 2081250
Depreciation & amortization: 53756250
Net tangible assets: -53848958.333333336
Owner earnings: 15198958.333333328
Buffett classification: The Gruesome
Stock price: 3.5937500000000004
Shares outstanding: 23000000
Book value: 113556250
P/B ratio: 0.7278881611536134
Market cap (USD): 82656250.00000001
Debt to equity: 1.5700460491313044
Current ratio: 0.6939540486646745
Quick ratio: 0.6939540486646745
Interest coverage ratio: -4.077957980095835
COGS to revenue (%): 1.2708386235731117
SG&A to revenue (%): 0.8787211300542705
Free cash flow (dilution-adjusted): -86298958.33333334
Buyback yield (%): 0
Retained earnings: -8747916.666666668
Receivables turnover: 2.497743229689067
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.300640981459782
FCF margin (%): -48.92433431559553
Rule of 40 score: -48.92433431559553
Financial ratios for SLBEN.LS — annual report dated 2023-06-30
Total revenue: 212822826.0869565
Gross profit: 210295652.17391303
Operating income: -53255434.782608695
Net income: 4579347.826086956
Capital expenditures: 1405434.7826086956
Depreciation & amortization: 50970652.17391304
Net tangible assets: -65948913.04347826
Owner earnings: 54144565.2173913
Return on net tangible assets (%): -82.10076969986649
Buffett classification: The Gruesome
Stock price: 3.945652173913043
P/E ratio: 19.817232375979113
Shares outstanding: 23000000
Book value: 123059782.60869569
P/B ratio: 0.7374464514419464
Market cap (USD): 90749999.99999999
Debt to equity: 1.496674468930795
Current ratio: 0.7420597611714487
Quick ratio: 0.7420597611714487
Effective tax rate (%): -133.66611203549638
Interest coverage ratio: -2.8590184979868125
COGS to revenue (%): 1.1874543532331956
SG&A to revenue (%): 1.026062707804512
Free cash flow (dilution-adjusted): -152461956.52173913
Buyback yield (%): 0
Retained earnings: -4561956.52173913
Receivables turnover: 2.967700375894265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -13.143775384829997
FCF margin (%): -71.6379719811846
Revenue growth (%): 20.652847897079923
Rule of 40 score: -50.98512408410468
Financial ratios for SLBEN.LS — annual report dated 2024-06-30
Total revenue: 189853763.4408602
Gross profit: 189577419.3548387
Operating income: -74711827.95698924
Net income: -33720430.10752688
Capital expenditures: 2958064.5161290322
Depreciation & amortization: 53464516.129032254
Net tangible assets: -121453763.44086021
Owner earnings: 16786021.50537634
Buffett classification: The Gruesome
Stock price: 3.548387096774193
Shares outstanding: 23000000
Book value: 88030107.5268817
P/B ratio: 0.9271021644598624
Market cap (USD): 81612903.22580644
Debt to equity: 2.7143328284555635
Current ratio: 0.4798392869072273
Quick ratio: 0.4798392869072273
Interest coverage ratio: -2.420638238573021
COGS to revenue (%): 1.5501461226524091
SG&A to revenue (%): 0.6060125506898347
Free cash flow (dilution-adjusted): -176437634.40860215
Buyback yield (%): 0
Retained earnings: -38219354.838709675
Receivables turnover: 4.235367491844176
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -19.53612870755415
FCF margin (%): -92.93344056546069
Revenue growth (%): -10.792574776124551
Rule of 40 score: -103.72601534158524
Financial ratios for SLBEN.LS — annual report dated 2025-06-30
Total revenue: 271315294.11764705
Operating income: -43921176.47058824
Net income: 40522352.941176474
Capital expenditures: 3342352.941176471
Depreciation & amortization: 59269411.76470588
Net tangible assets: -74954117.64705883
Owner earnings: 96449411.76470588
Return on net tangible assets (%): -128.67793630613235
Buffett classification: The Gruesome
Stock price: 6.188235294117647
P/E ratio: 3.5123679015213094
Shares outstanding: 23000000
Book value: 136843529.41176462
P/B ratio: 1.040088723058539
Market cap (USD): 142329411.7647059
Debt to equity: 1.7478012672266316
Current ratio: 0.48482661856083387
Quick ratio: 0.48482661856083387
Effective tax rate (%): 7.351319364122978
Interest coverage ratio: -1.4712512315270936
COGS to revenue (%): 0
Free cash flow (dilution-adjusted): -127436470.5882353
Buyback yield (%): 0
Retained earnings: -1288235.294117647
Receivables turnover: 3.6364181081379394
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.924291060826413
FCF margin (%): -46.96988092863524
Revenue growth (%): 42.90751428910296
Rule of 40 score: -4.062366639532279
Financial ratios for SLBEN.LS — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -74954117.64705883
Buffett classification: The Gruesome
Stock price: 6.188235294117647
Shares outstanding: 23000000
Book value: 136843529.41176462
P/B ratio: 1.040088723058539
Market cap (USD): 142329411.7647059
Debt to equity: 1.7478012672266316
Current ratio: 0.48482661856083387
Quick ratio: 0.48482661856083387
Buyback yield (%): 0
Retained earnings: -1288235.294117647
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLCE3.SA — annual report dated 2021-12-31
Operating income: 343512926.3913824
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.2719298245614032
Shares outstanding: 496311324
Market cap (USD): 1127584499.2631578
Buyback yield (%): 1.134166833252622
Retained earnings: 141706642.72890484
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLCE3.SA — annual report dated 2022-12-31
Total revenue: 1802716666.6666665
Gross profit: 593049053.030303
Operating income: 467867045.45454544
Net income: 253169128.78787878
Capital expenditures: 80810037.87878788
Operating cash flow: 377230492.4242424
Depreciation & amortization: 92529734.84848484
Net tangible assets: 846084090.9090909
Owner earnings: 264888825.75757575
Return on net tangible assets (%): 31.307623982500488
Capex to operating income (%): 17.272008931571307
Buffett classification: The Great
Stock price: 2.9734345351043645
P/E ratio: 5.829104196118036
Shares outstanding: 496311324
Book value: 927354545.4545455
P/B ratio: 1.5913538550906967
Market cap (USD): 1475749230.9449716
Debt to equity: 1.3729311465981757
Current ratio: 1.5322784327481813
Quick ratio: 0.41722273181848873
Effective tax rate (%): 25.97660349147897
Interest coverage ratio: 3.7879207926864797
COGS to revenue (%): 67.10248127195236
SG&A to revenue (%): 5.587295437105447
Free cash flow (dilution-adjusted): 286216666.6666666
Buyback yield (%): 0
Retained earnings: 0
Inventory turnover: 1.2480157334458826
Receivables turnover: 54.61179292103436
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.033566894020343
FCF margin (%): 15.876963471797195
Rule of 40 score: 15.876963471797195
Financial ratios for SLCE3.SA — annual report dated 2023-12-31
Total revenue: 1880850309.2783506
Gross profit: 540349278.3505155
Operating income: 389442061.85567015
Net income: 193397938.1443299
Capital expenditures: 165311958.7628866
Operating cash flow: 371525979.3814433
Depreciation & amortization: 107057731.9587629
Net tangible assets: 987439381.443299
Owner earnings: 135143711.34020618
Return on net tangible assets (%): 13.686279267358392
Capex to operating income (%): 42.44840887889309
Buffett classification: The Good
Stock price: 3.0538302277432714
P/E ratio: 7.836952855574799
Shares outstanding: 496311324
Book value: 1080797113.402062
P/B ratio: 1.4023450884612558
Market cap (USD): 1515650523.6024845
Debt to equity: 1.4630900522829084
Current ratio: 1.8234393489421745
Quick ratio: 0.5524880844745597
Effective tax rate (%): 23.36169882466368
Interest coverage ratio: 2.403140581880456
COGS to revenue (%): 71.27101100577016
SG&A to revenue (%): 5.897858875849528
Free cash flow (dilution-adjusted): 198203092.78350517
Buyback yield (%): 2.6358931173720648
Inventory turnover: 1.2660899240240497
Receivables turnover: 63.48298467576934
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.985052811014489
FCF margin (%): 10.537951468320317
Revenue growth (%): 4.334216466537582
Rule of 40 score: 14.872167934857899
Financial ratios for SLCE3.SA — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 1284898.7108655619
Buffett classification: The Gruesome
Stock price: 2.74585635359116
Shares outstanding: 496311324
Market cap (USD): 1362799602.364641
Buyback yield (%): 0
Retained earnings: 100400920.81031308
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLCE3.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Depreciation & amortization: 1151132.6860841424
Buffett classification: The Gruesome
Stock price: 2.316639741518578
Shares outstanding: 496311324
Market cap (USD): 1149774537.344103
Buyback yield (%): 0.06026227198422572
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SLCE3.SA — annual report dated 2024-12-31
Total revenue: 1262722815.5339806
Gross profit: 373418446.60194176
Operating income: 239750970.87378642
Net income: 82428802.58899677
Capital expenditures: 131029935.27508092
Operating cash flow: 239503398.05825242
Depreciation & amortization: 93091262.13592233
Net tangible assets: 627167313.9158577
Owner earnings: 44490129.44983816
Return on net tangible assets (%): 7.093821451257434
Capex to operating income (%): 54.65251498149713
Buffett classification: The Good
Stock price: 2.316639741518578
P/E ratio: 13.948698770708383
Shares outstanding: 496311324
Book value: 664165372.1682849
P/B ratio: 1.731157006259543
Market cap (USD): 1149774537.344103
Debt to equity: 2.1111858521608498
Current ratio: 1.3652672969918667
Quick ratio: 0.4595721588380452
Effective tax rate (%): 6.3189399007421
Interest coverage ratio: 1.701505752221536
COGS to revenue (%): 70.42752043376753
SG&A to revenue (%): 7.789557343014986
Free cash flow (dilution-adjusted): 105178802.58899677
Buyback yield (%): 0.04133355740720947
Inventory turnover: 0.987414017435286
Receivables turnover: 31.07071274143265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.96423249364743
FCF margin (%): 8.329524207141116
Revenue growth (%): -32.86425776124282
Rule of 40 score: -24.534733554101702
Financial ratios for SLCE3.SA — quarterly report dated 2025-03-31
Total revenue: 492130555.5555556
Gross profit: 186815104.1666667
Operating income: 148786111.1111111
Net income: 88663194.44444445
Capital expenditures: 150288541.6666667
Operating cash flow: -26596180.555555556
Depreciation & amortization: 32847395.833333336
Net tangible assets: 832212847.2222222
Owner earnings: -28777951.388888896
Return on net tangible assets (%): -3.4580037408632367
Capex to operating income (%): 101.0097922073073
Buffett classification: The Gruesome
Stock price: 2.6458333333333335
P/E ratio: 3.7026554619933427
Shares outstanding: 496311324
Book value: 884507465.2777777
P/B ratio: 1.484619515718396
Market cap (USD): 1313157044.75
Debt to equity: 1.892346906028799
Current ratio: 1.4366900082931542
Quick ratio: 0.40579903183283905
Effective tax rate (%): 30.407173225771288
Interest coverage ratio: 3.562598469385634
COGS to revenue (%): 62.039523443982226
SG&A to revenue (%): 7.314990940750818
Free cash flow (dilution-adjusted): -177553472.22222224
Buyback yield (%): 0
Retained earnings: 80044270.83333334
Inventory turnover: 0.3173497849798243
Receivables turnover: 8.766032717939202
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.086476532570614
FCF margin (%): -36.078530426095156
Rule of 40 score: -36.078530426095156
Financial ratios for SLCE3.SA — quarterly report dated 2025-06-30
Total revenue: 411470620.43795615
Gross profit: 119712956.20437956
Operating income: 83499635.03649634
Net income: 29505109.489051092
Capital expenditures: 47832116.78832117
Operating cash flow: 10036678.832116788
Depreciation & amortization: 36758576.642335765
Net tangible assets: 923790145.9854014
Owner earnings: 18431569.343065694
Return on net tangible assets (%): 1.9952117288937792
Capex to operating income (%): 57.284222580631074
Buffett classification: The Good
Stock price: 2.7481751824817517
P/E ratio: 11.542439199001143
Shares outstanding: 496311324
Book value: 958694708.0291967
P/B ratio: 1.4227161702032898
Market cap (USD): 1363950463.40146
Debt to equity: 1.9145896174600239
Current ratio: 1.7292151906672655
Quick ratio: 0.49502846206308787
Effective tax rate (%): 21.44606603974968
Interest coverage ratio: 1.055124610304562
COGS to revenue (%): 70.9060743931217
SG&A to revenue (%): 4.800300151805501
Free cash flow (dilution-adjusted): -39456751.824817516
Buyback yield (%): 0
Retained earnings: 113696350.3649635
Inventory turnover: 0.29015377043539614
Receivables turnover: 14.604860386939652
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4807401827339524
FCF margin (%): -9.589202695157436
Revenue growth (%): -16.389946571503604
Rule of 40 score: -25.97914926666104
Financial ratios for SLCE3.SA — quarterly report dated 2025-09-30
Total revenue: 447187218.0451127
Gross profit: 117024812.03007518
Operating income: 53391165.41353383
Net income: -2065413.5338345864
Capital expenditures: 32306766.917293232
Operating cash flow: 197283082.7067669
Depreciation & amortization: 38102819.54887218
Net tangible assets: 881976503.7593985
Owner earnings: 3730639.0977443643
Capex to operating income (%): 60.5095743220169
Buffett classification: The Good
Stock price: 2.5996240601503757
P/E ratio: 11.112753995651227
Shares outstanding: 496311324
Book value: 1003175939.8496242
P/B ratio: 1.286138161755447
Market cap (USD): 1290222859.1954887
Debt to equity: 2.1920888096751368
Current ratio: 1.5471938834749548
Quick ratio: 0.5202763500178981
Interest coverage ratio: 0.555881512562283
COGS to revenue (%): 73.83091302527579
SG&A to revenue (%): 9.162072368808207
Free cash flow (dilution-adjusted): 163963721.80451128
Buyback yield (%): 0
Retained earnings: 115103195.4887218
Inventory turnover: 0.2942159624601884
Receivables turnover: 8.540724891582181
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.9306815443630707
FCF margin (%): 36.665565380263274
Revenue growth (%): 8.680230333125843
Rule of 40 score: 45.345795713389116
Financial ratios for SLCE3.SA — quarterly report dated 2025-12-31
Total revenue: 418001277.3722627
Gross profit: 104794708.02919707
Operating income: 40591058.39416058
Net income: -10182299.270072991
Capital expenditures: 38924817.51824817
Operating cash flow: 156373722.62773722
Depreciation & amortization: 22538138.686131384
Net tangible assets: 831680656.9343065
Owner earnings: -26568978.10218978
Return on net tangible assets (%): -3.194612966006306
Capex to operating income (%): 95.89505437445771
Buffett classification: The Gruesome
Stock price: 2.5619389587073607
P/E ratio: 12.004458274289636
Shares outstanding: 496311324
Book value: 1032013686.1313868
P/B ratio: 1.232076021559033
Market cap (USD): 1271519316.6032314
Debt to equity: 2.0076508703574527
Current ratio: 1.8012921934173693
Quick ratio: 0.6902158839349419
Interest coverage ratio: 0.6312564739269244
COGS to revenue (%): 74.9295722998786
SG&A to revenue (%): 13.142575001735318
Free cash flow (dilution-adjusted): 116255839.41605839
Buyback yield (%): 0
Inventory turnover: 0.2826219259177294
Receivables turnover: 9.23331519438902
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4011435963216856
FCF margin (%): 27.8123167821144
Revenue growth (%): -6.52655968129789
Rule of 40 score: 21.28575710081651
Financial ratios for SLCE3.SA — annual report dated 2025-12-31
Total revenue: 1780878467.1532845
Gross profit: 534476094.8905109
Operating income: 344368613.1386861
Net income: 103141058.39416057
Capital expenditures: 276087956.20437956
Operating cash flow: 329978284.6715328
Depreciation & amortization: 130812773.72262773
Net tangible assets: 831680656.9343065
Owner earnings: -42134124.08759126
Return on net tangible assets (%): -5.066142122735384
Capex to operating income (%): 80.1722182773933
Buffett classification: The Gruesome
Stock price: 2.5619389587073607
P/E ratio: 12.327964599161218
Shares outstanding: 496311324
Book value: 1032013686.1313868
P/B ratio: 1.232076021559033
Market cap (USD): 1271519316.6032314
Debt to equity: 2.0076508703574527
Current ratio: 1.8012921934173693
Quick ratio: 0.6902158839349419
Effective tax rate (%): 20.803131931493198
Interest coverage ratio: 1.561603458277167
COGS to revenue (%): 69.98806461258047
SG&A to revenue (%): 7.969873393492549
Free cash flow (dilution-adjusted): 49349999.99999999
Buyback yield (%): 0
Inventory turnover: 1.1246910933451362
Receivables turnover: 39.33818650865631
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.887097704820224
FCF margin (%): 2.771104312294002
Revenue growth (%): 41.03478968186586
Rule of 40 score: 43.80589399415986
Financial ratios for SPX.V — annual report dated 2021-07-31
Capital expenditures: 983028.2258064516
Buffett classification: The Gruesome
Stock price: 0.40322580645161293
Shares outstanding: 64970803
Market cap (USD): 26197904.435483873
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPX.V — annual report dated 2022-07-31
Total revenue: 0
Operating income: -1270214.0625
Net income: -1239735.15625
Capital expenditures: 56207.03125
Operating cash flow: -1300835.9375
Net tangible assets: 882160.9375
Owner earnings: -1295942.1875
Return on net tangible assets (%): -146.90541514710858
Buffett classification: The Gruesome
Stock price: 0.46875
Shares outstanding: 64970803
Book value: 882160.9375
P/B ratio: 34.52325149712266
Market cap (USD): 30455063.90625
Debt to equity: 0
Current ratio: 3.5078459560231985
Quick ratio: 3.5078459560231985
Free cash flow (dilution-adjusted): -1368578.125
Buyback yield (%): 0
Retained earnings: -19265621.09375
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -143.98892634032552
Rule of 40 score: 0
Financial ratios for SPX.V — annual report dated 2023-07-31
Total revenue: 0
Operating income: -837067.6691729323
Net income: -877000.7518796992
Capital expenditures: 0
Operating cash flow: -571463.909774436
Net tangible assets: -18605.263157894737
Owner earnings: -877000.7518796992
Buffett classification: The Gruesome
Stock price: 0.22556390977443608
Shares outstanding: 64970803
Book value: -18605.26315789472
Market cap (USD): 14655068.345864661
Debt to equity: 0
Current ratio: 0.9373369799184583
Quick ratio: 0.9373369799184583
Free cash flow (dilution-adjusted): -571463.909774436
Buyback yield (%): 0
Retained earnings: -19418350.37593985
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPX.V — annual report dated 2024-07-31
Total revenue: 0
Operating income: -458986.9565217392
Net income: -500680.43478260876
Capital expenditures: 0
Operating cash flow: -55673.913043478264
Net tangible assets: -395876.81159420294
Owner earnings: -500680.43478260876
Buffett classification: The Gruesome
Stock price: 0.05072463768115943
Shares outstanding: 64970803
Book value: -395876.8115942029
Market cap (USD): 3295620.4420289863
Debt to equity: 0
Current ratio: 0.27715163527721254
Quick ratio: 0.27715163527721254
Interest coverage ratio: -4.619528275741354
Free cash flow (dilution-adjusted): -110977.53623188406
Buyback yield (%): 0
Retained earnings: -19215467.391304348
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPX.V — quarterly report dated 2024-10-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.06474820143884892
Shares outstanding: 64970803
Market cap (USD): 4206742.64028777
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPX.V — quarterly report dated 2025-01-31
Total revenue: 0
Operating income: -157482.06896551725
Net income: -164588.9655172414
Capital expenditures: 0
Operating cash flow: -154082.06896551725
Net tangible assets: -89894.4827586207
Owner earnings: -164588.9655172414
Buffett classification: The Gruesome
Stock price: 0.06896551724137931
Shares outstanding: 64970803
Book value: -89894.4827586207
Market cap (USD): 4480745.0344827585
Debt to equity: 0
Current ratio: 0.6394752563974908
Quick ratio: 0.6394752563974908
Free cash flow (dilution-adjusted): -154082.06896551725
Buyback yield (%): 0
Retained earnings: -18690135.862068966
Receivables turnover: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SPX.V — quarterly report dated 2025-04-30
Total revenue: 0
Operating income: -298134.0579710145
Net income: -343474.6376811594
Capital expenditures: 0
Operating cash flow: -94627.53623188406
Net tangible assets: 570815.2173913044
Owner earnings: -343474.6376811594
Return on net tangible assets (%): -60.172649084388574
Buffett classification: The Gruesome
Stock price: 0.05797101449275363
Shares outstanding: 64970803
Book value: 570815.2173913044
P/B ratio: 6.598323323494873
Market cap (USD): 3766423.3623188413
Debt to equity: 0
Current ratio: 3.1479054700728852
Quick ratio: 3.1479054700728852
Free cash flow (dilution-adjusted): -165830.4347826087
Buyback yield (%): 0
Retained earnings: -19981660.86956522
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -52.22952172395189
Rule of 40 score: 0
Financial ratios for SPX.V — quarterly report dated 2025-07-31
Total revenue: 0
Operating income: -183242.75362318842
Net income: -199894.9275362319
Capital expenditures: 0
Operating cash flow: -338830.4347826087
Net tangible assets: 370921.01449275366
Owner earnings: -199894.9275362319
Return on net tangible assets (%): -53.89150782130654
Buffett classification: The Gruesome
Stock price: 0.07246376811594205
Shares outstanding: 64970803
Book value: 370921.0144927536
P/B ratio: 12.69280795356643
Market cap (USD): 4708029.202898552
Debt to equity: 0
Current ratio: 2.468025123322244
Quick ratio: 2.468025123322244
Interest coverage ratio: -46.56998158379374
Free cash flow (dilution-adjusted): -338831.15942028986
Buyback yield (%): 0
Retained earnings: -20181555.79710145
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -49.402095449830135
Rule of 40 score: 0
Financial ratios for SPX.V — annual report dated 2025-07-31
Total revenue: 0
Operating income: -784318.115942029
Net income: -966088.4057971016
Capital expenditures: 0
Operating cash flow: -819536.231884058
Net tangible assets: 370921.01449275366
Owner earnings: -966088.4057971016
Return on net tangible assets (%): -260.4566384889943
Buffett classification: The Gruesome
Stock price: 0.07246376811594205
Shares outstanding: 64970803
Book value: 370921.0144927536
P/B ratio: 12.69280795356643
Market cap (USD): 4708029.202898552
Debt to equity: 0
Current ratio: 2.468025123322244
Quick ratio: 2.468025123322244
Interest coverage ratio: -199.32946593001842
Free cash flow (dilution-adjusted): -941359.4202898551
Buyback yield (%): 0
Retained earnings: -20181555.79710145
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -211.4515180582608
Rule of 40 score: 0
Financial ratios for SPX.V — quarterly report dated 2025-10-31
Total revenue: 0
Operating income: -302961.4285714286
Net income: -288941.4285714286
Capital expenditures: 0
Operating cash flow: -365642.85714285716
Net tangible assets: 2916654.285714286
Owner earnings: -288941.4285714286
Return on net tangible assets (%): -9.906605317834819
Buffett classification: The Gruesome
Stock price: 0.1142857142857143
Shares outstanding: 64970803
Book value: 2916654.285714286
P/B ratio: 2.5458055364806444
Market cap (USD): 7425234.628571429
Debt to equity: 0
Current ratio: 11.97999123389632
Quick ratio: 11.97999123389632
Free cash flow (dilution-adjusted): -368428.5714285714
Buyback yield (%): 0
Retained earnings: -20182189.285714287
Receivables turnover: 0
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -10.387293072591001
Rule of 40 score: 0
Financial ratios for STARHEALTH.NS — annual report dated 2022-03-31
Capital expenditures: 0
Depreciation & amortization: 5709996.043782145
Buffett classification: The Gruesome
Stock price: 9.368983252011079
Shares outstanding: 588403502
Market cap (USD): 5512742555.662667
Buyback yield (%): 0
Retained earnings: 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STARHEALTH.NS — annual report dated 2023-03-31
Total revenue: 1490998501.8270402
Net income: 75346187.57612668
Capital expenditures: 5665030.450669915
Depreciation & amortization: 6341948.842874544
Net tangible assets: 802544543.2399514
Owner earnings: 76023105.9683313
Return on net tangible assets (%): 9.472758441720698
Buffett classification: The Gruesome
Stock price: 6.313032886723508
P/E ratio: 49.30057881211563
Shares outstanding: 588403502
Book value: 802544543.2399514
P/B ratio: 4.628541418764162
Market cap (USD): 3714610658.7892814
Debt to equity: 0.07133218949890911
Effective tax rate (%): 25.14640560269157
COGS to revenue (%): 0
SG&A to revenue (%): 1.339845527088637
Free cash flow (dilution-adjusted): 149722862.362972
Buyback yield (%): 0
Retained earnings: 0
Receivables turnover: 3880.888244245767
Capitalized R&D asset: 0
FCF margin (%): 10.041784896463984
Rule of 40 score: 10.041784896463984
Financial ratios for STARHEALTH.NS — annual report dated 2024-03-31
Total revenue: 1728423072.3108287
Net income: 101332294.04005276
Capital expenditures: 14700803.453651518
Depreciation & amortization: 7040412.519486749
Net tangible assets: 807265859.2157333
Owner earnings: 93671903.105888
Return on net tangible assets (%): 11.603600231142089
Buffett classification: The Gruesome
Stock price: 6.519313819577736
P/E ratio: 37.855523931593986
Shares outstanding: 588403502
Book value: 807265859.215733
P/B ratio: 4.7518262271158545
Market cap (USD): 3835987082.0765357
Debt to equity: 0.06981798303274465
Effective tax rate (%): 25.14417327368561
COGS to revenue (%): 0
SG&A to revenue (%): 1.5725731476162328
Free cash flow (dilution-adjusted): 142279649.8381101
Buyback yield (%): 0
Retained earnings: 0
Receivables turnover: 354.2226591300074
Capitalized R&D asset: 0
FCF margin (%): 8.231760621425181
Revenue growth (%): 15.92386378610395
Rule of 40 score: 24.15562440752913
Financial ratios for STARHEALTH.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 837902532.2503583
Buffett classification: The Gruesome
Stock price: 7.251552795031056
Shares outstanding: 588403502
Book value: 837902532.2503581
P/B ratio: 5.092285672027623
Market cap (USD): 4266839059.5341616
Debt to equity: 0.06700005131918826
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STARHEALTH.NS — quarterly report dated 2024-12-31
Total revenue: 483378016.0857909
Net income: 25077514.86187201
Capital expenditures: 0
Owner earnings: 25077514.86187201
Buffett classification: The Gruesome
Stock price: 5.536193029490616
P/E ratio: 32.47446352083527
Shares outstanding: 588403502
Market cap (USD): 3257515366.3002677
Effective tax rate (%): 25.02787844995818
COGS to revenue (%): 0
SG&A to revenue (%): 1.3894716535243192
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for STARHEALTH.NS — quarterly report dated 2025-03-31
Total revenue: 477101940.61257887
Net income: 59621.229833995785
Capital expenditures: 0
Net tangible assets: 824880757.540332
Owner earnings: 59621.229833995785
Return on net tangible assets (%): 0.007227860425763495
Buffett classification: The Gruesome
Stock price: 4.162095927179367
P/E ratio: 10268.958834089124
Shares outstanding: 588403502
Book value: 831440261.8657937
P/B ratio: 2.9454813911905298
Market cap (USD): 2448991819.2122765
Debt to equity: 0.06608418844398452
COGS to revenue (%): 0
SG&A to revenue (%): 1.1663436352186771
Buyback yield (%): 0
Retained earnings: 41999064.76502221
Receivables turnover: 76.43997003184117
Capitalized R&D asset: 0
Revenue growth (%): -1.2983783424892277
Rule of 40 score: -1.2983783424892277
Financial ratios for STARHEALTH.NS — annual report dated 2025-03-31
Total revenue: 1882401215.805471
Net income: 75503857.84428337
Capital expenditures: 9568622.866495207
Depreciation & amortization: 8356324.526537292
Net tangible assets: 824880757.540332
Owner earnings: 74291559.50432546
Return on net tangible assets (%): 9.006339258761656
Buffett classification: The Gruesome
Stock price: 4.162095927179367
P/E ratio: 32.43532038141674
Shares outstanding: 588403502
Book value: 831440261.8657937
P/B ratio: 2.9454813911905298
Market cap (USD): 2448991819.2122765
Debt to equity: 0.06608418844398452
Effective tax rate (%): 24.99158004761628
COGS to revenue (%): 0
SG&A to revenue (%): 1.276047909397928
Free cash flow (dilution-adjusted): 151497545.0081833
Buyback yield (%): 0
Retained earnings: 41999064.76502221
Receivables turnover: 301.5931822438659
Capitalized R&D asset: 0
FCF margin (%): 8.048100677801475
Revenue growth (%): 8.90859107132723
Rule of 40 score: 16.956691749128705
Financial ratios for STARHEALTH.NS — quarterly report dated 2025-06-30
Total revenue: 495235197.75333494
Net income: 30718464.778843906
Capital expenditures: 0
Net tangible assets: 897176456.821905
Owner earnings: 30718464.778843906
Return on net tangible assets (%): 3.423904466648494
Buffett classification: The Gruesome
Stock price: 4.9461736484905225
P/E ratio: 52.10481761742952
Shares outstanding: 588403502
Book value: 897176456.8219051
P/B ratio: 3.2438946364925196
Market cap (USD): 2910345896.2719407
Debt to equity: 0.06129952382008198
Effective tax rate (%): 25.424691778876202
COGS to revenue (%): 0
SG&A to revenue (%): 1.2184921602540473
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 3.8007091560922452
Rule of 40 score: 3.8007091560922452
Financial ratios for STARHEALTH.NS — quarterly report dated 2025-12-31
Total revenue: 508702239.0553637
Net income: 14283168.096245963
Capital expenditures: 0
Net tangible assets: 1064397905.7591623
Owner earnings: 14283168.096245963
Return on net tangible assets (%): 1.3419011836610817
Buffett classification: The Gruesome
Stock price: 5.068508410382088
P/E ratio: 42.52039410610594
Shares outstanding: 588403502
Book value: 1073025509.6357358
P/B ratio: 2.77936365147339
Market cap (USD): 2982328098.5852737
Debt to equity: 0.049807164250380224
Effective tax rate (%): 26.063891131357398
COGS to revenue (%): 0
SG&A to revenue (%): 1.7938869448300931
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 2.719322326668791
Rule of 40 score: 2.719322326668791
Financial ratios for SXI — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 91.15
Shares outstanding: 12114922
Market cap (USD): 1104275140.3
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SXI — annual report dated 2022-06-30
Total revenue: 735339000
Gross profit: 269946000
Operating income: 94311000
Net income: 61393000
Capital expenditures: 23891000
Operating cash flow: 77716000
Depreciation & amortization: 29697000
Net tangible assets: 145667000
Owner earnings: 67199000
Return on net tangible assets (%): 46.13193104821271
Capex to operating income (%): 25.332145773027538
Buffett classification: The Good
Stock price: 82.24
P/E ratio: 16.228742450768003
Shares outstanding: 12114922
Book value: 499343000
P/B ratio: 1.9952841739645892
Market cap (USD): 996331185.28
Debt to equity: 0.4287193372090927
Current ratio: 2.5137827655735965
Quick ratio: 1.815100021224663
Effective tax rate (%): 24.36615040165336
Interest coverage ratio: 16.055669050051073
COGS to revenue (%): 63.28958480374358
SG&A to revenue (%): 23.10362975443979
Free cash flow (dilution-adjusted): 42657000
Buyback yield (%): 3.154071704698132
Retained earnings: 901421000
Inventory turnover: 4.418050294762623
Receivables turnover: 5.949104000647223
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.034514483756578
FCF margin (%): 5.800997907087751
Rule of 40 score: 5.800997907087751
Financial ratios for SXI — annual report dated 2023-06-30
Total revenue: 741048000
Gross profit: 285096000
Operating income: 113372000
Net income: 138992000
Capital expenditures: 24270000
Operating cash flow: 90801000
Depreciation & amortization: 28474000
Net tangible assets: 266977000
Owner earnings: 143196000
Return on net tangible assets (%): 53.63608101072377
Capex to operating income (%): 21.40740218043256
Buffett classification: The Great
Stock price: 138.61
P/E ratio: 12.081625837602164
Shares outstanding: 12114922
Book value: 607449000
P/B ratio: 2.764428517324088
Market cap (USD): 1679249338.42
Debt to equity: 0.3411825519508634
Current ratio: 3.428128569097732
Quick ratio: 2.729120999950343
Effective tax rate (%): 15.124215457245851
Interest coverage ratio: 20.975393154486586
COGS to revenue (%): 61.527998186352306
SG&A to revenue (%): 23.255578586002525
Free cash flow (dilution-adjusted): 54821000
Buyback yield (%): 1.5201435198431144
Retained earnings: 1027279000
Inventory turnover: 4.627216172605214
Receivables turnover: 4.794006909133254
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.825438197569577
FCF margin (%): 7.397766406494586
Revenue growth (%): 0.7763766099717273
Rule of 40 score: 8.174143016466314
Financial ratios for SXI — annual report dated 2024-06-30
Total revenue: 720635000
Gross profit: 282001000
Operating income: 112292000
Net income: 73074000
Capital expenditures: 20298000
Operating cash flow: 92656000
Depreciation & amortization: 28140000
Net tangible assets: 261547000
Owner earnings: 80916000
Return on net tangible assets (%): 30.93746057114018
Capex to operating income (%): 18.076087343711038
Buffett classification: The Great
Stock price: 159.1
P/E ratio: 26.377153162547554
Shares outstanding: 12114922
Book value: 621503000
P/B ratio: 3.101327089652021
Market cap (USD): 1927484090.2
Debt to equity: 0.3023155157738579
Current ratio: 3.3715752753498216
Quick ratio: 2.688739074197468
Effective tax rate (%): 22.635955552284937
Interest coverage ratio: 24.712147887323944
COGS to revenue (%): 60.86770695289571
SG&A to revenue (%): 23.53466040367176
Free cash flow (dilution-adjusted): 62547000
Buyback yield (%): 1.6510642117257563
Retained earnings: 1086277000
Inventory turnover: 5.035634743875279
Receivables turnover: 4.321441849866273
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.79692578393877
FCF margin (%): 8.6794285595343
Revenue growth (%): -2.7546123867819627
Rule of 40 score: 5.924816172752337
Financial ratios for SXI — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 180.78
Shares outstanding: 12114922
Market cap (USD): 2190135599.16
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SXI — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 185.23
Shares outstanding: 12114922
Market cap (USD): 2244047002.06
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for SXI — quarterly report dated 2025-03-31
Total revenue: 207780000
Gross profit: 82430000
Operating income: 30381000
Net income: 22726000
Capital expenditures: 6072000
Operating cash flow: 9540000
Depreciation & amortization: 9744000
Net tangible assets: -150635000
Owner earnings: 26398000
Return on net tangible assets (%): -17.52447970259236
Capex to operating income (%): 19.98617557025773
Buffett classification: The Great
Stock price: 160.14
P/E ratio: 21.342114858312065
Shares outstanding: 12114922
Book value: 714500000
P/B ratio: 2.715302461973408
Market cap (USD): 1940083609.08
Debt to equity: 0.8761539538138559
Current ratio: 3.403166282239463
Quick ratio: 2.564653666037604
Effective tax rate (%): -29.56032080086457
Interest coverage ratio: 3.6327872772928376
COGS to revenue (%): 60.32823178361729
SG&A to revenue (%): 25.05005294061026
Free cash flow (dilution-adjusted): 745000
Buyback yield (%): 0
Retained earnings: 1115862000
Inventory turnover: 1.044879382491706
Receivables turnover: 0.9101661059714046
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.15241242208566
FCF margin (%): 0.3585523149485032
Rule of 40 score: 0.3585523149485032
Financial ratios for SXI — quarterly report dated 2025-06-30
Total revenue: 222049000
Gross profit: 91298000
Operating income: 38697000
Net income: 15486000
Capital expenditures: 8581000
Operating cash flow: 33424000
Depreciation & amortization: 10128000
Net tangible assets: -124418000
Owner earnings: 17033000
Return on net tangible assets (%): -13.690141297882944
Capex to operating income (%): 22.174845595265783
Buffett classification: The Great
Stock price: 155.59
P/E ratio: 49.32902527949335
Shares outstanding: 12114922
Book value: 739590000
P/B ratio: 2.548656301437283
Market cap (USD): 1884960713.98
Debt to equity: 0.8162644167714544
Current ratio: 2.8799460997155264
Quick ratio: 2.1014223686180564
Effective tax rate (%): 40.67712127602469
Interest coverage ratio: 4.292036379769299
COGS to revenue (%): 58.88384996104463
SG&A to revenue (%): 23.688915509639763
Free cash flow (dilution-adjusted): 24030000
Buyback yield (%): 0.017188687148597927
Retained earnings: 1126851000
Inventory turnover: 1.0058233456928782
Receivables turnover: 0.9573966282930194
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.764259003289509
FCF margin (%): 10.821935698877274
Revenue growth (%): 6.867359707382809
Rule of 40 score: 17.689295406260083